We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 5,090 results
  1. Changes in spike protein antibody titer over 90 days after the second dose of SARS-CoV-2 vaccine in Japanese dialysis patients

    Objectives

    There is no report on antibody titers after vaccination against SARS-CoV-2 in Japanese dialysis patients. As dialysis is different between...

    Haruki Wakai, Natsumi Abe, ... Kazunari Yoshida in BMC Infectious Diseases
    Article Open access 14 November 2022
  2. Clinical significance of Mycoplasma pneumoniae specific IgM titer in children hospitalized with Mycoplasma pneumoniae pneumonia

    Background

    The present study aimed to identify the clinical significance of Mycoplasma pneumoniae (MP)-specific immunoglobulin M (IgM) titer, in...

    Soojeong Choo, Seo-Hee Kim, Eun Lee in BMC Infectious Diseases
    Article Open access 16 May 2022
  3. Production of a chimeric porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine using a lab-scale packed-bed bioreactor CelCradle

    Background

    We developed a MARC-145 cell culture and porcine reproductive and respiratory syndrome (PRRS) vaccine production using a novel CelCradle...

    Hwi-Yeon Choi, Jong-Chul Choi, ... Joong-Bok Lee in BMC Veterinary Research
    Article Open access 02 August 2023
  4. Neutralizing Antibody Responses Among Residents and Staff of Long-Term Care Facilities in the State of New Jersey During the First Wave of the COVID-19 Pandemic

    Expanding a previous study of the immune response to SARS-CoV-2 in 10 New Jersey long-term care facilities (LTCFs) during the first wave of the...

    Stephen M. Friedman, Jieliang Li, ... Edward Lifshitz in Journal of Community Health
    Article 05 October 2022
  5. Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach

    Background

    The currently recommended dose of rituximab for primary membranous nephropathy is as high as that for lymphoma. However, the clinical...

    Song Wang, Zhenling Deng, ... Danxia Zheng in BMC Nephrology
    Article Open access 26 May 2023
  6. C1-inhibitor/C1-inhibitor antibody complexes in acquired angioedema due to C1-inhibitor deficiency

    Background

    Autoantibodies against C1-inhibitor (C1-INH-Ab) have a diagnostic value in acquired angioedema due to C1-inhibitor deficiency (C1-INH-AAE),...

    Zsofia Polai, Erika Kajdacsi, ... Henriette Farkas in Orphanet Journal of Rare Diseases
    Article Open access 01 February 2023
  7. Clinical usefulness of anti-nuclear antibody in childhood: real-world experience at a tertiary care center

    We evaluated the reasons for requesting anti-nuclear antibody (ANA) analysis in clinical practice at a tertiary center and the performance of ANA in...

    Nihal Şahin, Ayşenur Paç Kısaarslan, ... Ruhan Düşünsel in European Journal of Pediatrics
    Article 12 May 2023
  8. The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy

    Background

    Most primary membranous nephropathy (MN) is mediated by anti-phospholipase A2 receptor (PLA2R) antibodies. Recently, these antibodies have...

    Yan-jiao Cheng, Miao Wang, ... Ming-hui Zhao in European Journal of Medical Research
    Article Open access 20 March 2023
  9. Efficacy of H2O2 inactivated bovine virus diarrhoea virus (BVDV) type 1 vaccine in mice

    Background

    Bovine viral diarrhea (BVD) is an acute febrile infectious disease caused by the bovine viral diarrhea virus (BVDV), which has brought huge...

    Cunyuan Li, **ming Yu, ... Shengwei Hu in BMC Veterinary Research
    Article Open access 03 February 2024
  10. Neuropsychiatric manifestations and magnetic resonance spectroscopy of the brain in systemic lupus erythematosus patients

    Background

    Neuropsychiatric manifestations of lupus (NPSLE) are considered one of the major and most devastating lupus manifestations. The aim of this...

    Dina A. Shahin, Khaled M. F. Hegazy, ... Samar Tharwat in Middle East Current Psychiatry
    Article Open access 24 April 2023
  11. Assessing the Impact of Immunogenicity and Improving Prediction of Trough Concentrations: Population Pharmacokinetic Modeling of Adalimumab in Patients with Crohn’s Disease and Ulcerative Colitis

    Background and Objective

    Predicting adalimumab pharmacokinetics (PK) for patients impacted by anti-drug antibodies (ADA) has been challenging. The...

    Ana Victoria Ponce-Bobadilla, Sven Stodtmann, ... Nael M. Mostafa in Clinical Pharmacokinetics
    Article 11 March 2023
  12. Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients

    Background

    The mortality rate of Coronavirus disease 2019 (COVID-19) is extremely high in hemodialysis patients (HDP). These patients also develop...

    Masataro Toda, Ayumi Yoshifuji, ... Munekazu Ryuzaki in Clinical and Experimental Nephrology
    Article 08 February 2022
  13. HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy

    Background

    High hemagglutination inhibition (HAI) and neuraminidase inhibition (NAI) titers are generally associated with reduced influenza risk....

    Peter B Gilbert, Youyi Fong, ... Joshua G Petrie in BMC Infectious Diseases
    Article Open access 22 May 2019
  14. Effect of Tezepelumab on the Humoral Immune Response to Seasonal Quadrivalent Influenza Vaccination in Patients with Moderate to Severe Asthma: The Phase 3b VECTOR Study

    Introduction

    Annual influenza vaccinations are recommended for adolescents and adults with moderate to severe asthma. This study investigated the...

    Jeremy Cole, Iwona Cąpała-Szczurko, ... Gene Colice in Pulmonary Therapy
    Article Open access 08 December 2023
  15. Value of biopsy in a cohort of children with high-titer celiac serologies: observation of dynamic policy differences between Europe and North America

    Background

    Healthcare systems implement change at different rates because of differences in incentives, organizational processes, key influencers, and...

    Kamran Badizadegan, David M. Vanlandingham, ... Kimberly M. Thompson in BMC Health Services Research
    Article Open access 20 October 2020
  16. Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study

    Background

    There are no data on pharmacokinetics, pharmacodynamics, and immunogenicity of intravitreal aflibercept in preterm infants with retinopathy...

    Andreas Stahl, Noriyuki Azuma, ... Torsten Zimmermann in Eye
    Article Open access 10 January 2024
  17. Long-term antibody production and viremia in American mink (Neovison vison) challenged with Aleutian mink disease virus

    Background

    Selecting American mink ( Neovison vison ) for tolerance to Aleutian mink disease virus (AMDV) has gained popularity in recent years, but...

    A. Hossain Farid, Irshad Hussain, ... Irin Arju in BMC Veterinary Research
    Article Open access 03 October 2022
  18. Multiple intracellular pathogen infections with ocular pathologies associated with adult-onset immunodeficiency due to anti-interferon-γ autoantibodies: a case report

    Background

    Autoantibodies against interferon-γ (IFN-γ) can inhibit IFN-γ-dependent signal transducer and activator of transcription 1 phosphorylation...

    Yan Ning, Qingliang Yu, ... Zhiyi He in BMC Infectious Diseases
    Article Open access 12 January 2024
  19. Role of H.pylori in Chronic Sore Throat by Using H.pylori Line

    Pharyngitis is an inflammation of the mucous membranes of the oropharynx. Pharyngitis may be caused by an infectious or noninfectious disease....

    Mahmoud Ahmed Shawky, Amira Ahmed Shawky in Indian Journal of Otolaryngology and Head & Neck Surgery
    Article 11 March 2024
  20. Subclinical hepatitis E virus (HEV) infection detected by nucleic acid amplification test on blood donation: short-term positivity for immunoglobulin G class of antibody against HEV

    A case of subclinical hepatitis E virus (HEV) infection was detected by nucleic acid amplification test on blood donation. The patient was...

    Izumi Hasegawa, Tatsunori Nakano, ... Hiroaki Okamoto in Clinical Journal of Gastroenterology
    Article 04 May 2022
Did you find what you were looking for? Share feedback.